APPLIED ENERGETICS, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that APPLIED ENERGETICS, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $461.7K | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $2.43M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $2.63M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.31M | Mar 26, 2024 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $1.9K | Apr 14, 2014 |
| FY2013 | Sep 30, 2013 | $2.1K | Apr 14, 2014 |
| FY2013 | Jun 30, 2013 | $4.3K | Apr 14, 2014 |
| FY2013 | Mar 31, 2013 | $34.5K | Apr 14, 2014 |
| FY2012 | Dec 31, 2012 | $119.9K | Mar 29, 2013 |
| FY2012 | Sep 30, 2012 | $312.0K | Mar 29, 2013 |
| FY2012 | Jun 30, 2012 | $504.3K | Mar 29, 2013 |
| FY2012 | Mar 31, 2012 | $399.2K | Mar 29, 2013 |
| FY2012 | Dec 31, 2011 | $619.6K | Mar 29, 2013 |
| FY2012 | Sep 30, 2011 | $611.2K | Mar 29, 2013 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $249.1K | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $946.5K | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $1.99M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.00M | Mar 26, 2024 |
| FY2021 | Dec 31, 2020 | $22.3K | Mar 31, 2022 |
| FY2015 | Dec 31, 2015 | $0 | Apr 1, 2016 |
| FY2015 | Dec 31, 2014 | $6.0K | Apr 1, 2016 |
| FY2013 | Dec 31, 2013 | $1.9K | Apr 14, 2014 |
| FY2013 | Sep 30, 2013 | $2.1K | Apr 14, 2014 |
| FY2013 | Jun 30, 2013 | ($2.7K) | Apr 14, 2014 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($14.87M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($9.17M) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($7.35M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($5.77M) | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | ($5.43M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($3.23M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($5.56M) | Apr 12, 2021 |
| FY2019 | Dec 31, 2018 | ($3.01M) | Apr 3, 2020 |
| FY2018 | Dec 31, 2017 | ($790.0K) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($492.6K) | Apr 17, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($14.93M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($9.18M) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($7.40M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($5.77M) | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | ($5.50M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($5.24M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($5.17M) | Apr 12, 2021 |
| FY2019 | Dec 31, 2018 | ($2.76M) | Apr 3, 2020 |
| FY2018 | Dec 31, 2017 | ($752.3K) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($495.2K) | Apr 17, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.67M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $239.1K | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $233.7K | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $320.5K | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $281.9K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $266.9K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $335.4K | Apr 12, 2021 |
| FY2019 | Dec 31, 2018 | $190.5K | Apr 3, 2020 |
| FY2013 | Dec 31, 2012 | $157.3K | Apr 14, 2014 |
| FY2012 | Dec 31, 2011 | $1.67M | Mar 29, 2013 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($9.24M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($5.09M) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($3.45M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($3.93M) | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | ($3.21M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($160.3K) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($3.25M) | Apr 12, 2021 |
| FY2019 | Dec 31, 2018 | ($1.79M) | Apr 3, 2020 |
| FY2018 | Dec 31, 2017 | ($200.4K) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($136.2K) | Apr 17, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.23M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $98.8K | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $369.3K | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $74.2K | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $207.4K | Mar 30, 2023 |
| FY2020 | Dec 31, 2019 | $12.4K | Apr 12, 2021 |
| FY2013 | Dec 31, 2012 | $15.1K | Apr 14, 2014 |
| FY2012 | Dec 31, 2011 | $237.2K | Mar 29, 2013 |
| FY2011 | Dec 31, 2010 | $80.7K | Mar 29, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.06M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $2.07M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $3.54M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $6.73M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $4.89M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $4.63M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $2.85M | Apr 12, 2021 |
| FY2019 | Dec 31, 2018 | $729.9K | Apr 3, 2020 |
| FY2018 | Dec 31, 2017 | $3.1K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $992 | Apr 17, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.50M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $1.68M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $1.92M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.15M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $1.92M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $2.93M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $5.77M | Apr 12, 2021 |
| FY2019 | Dec 31, 2018 | $1.37M | Apr 3, 2020 |
| FY2018 | Dec 31, 2017 | $864.8K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $348.9K | Apr 17, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.56M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $392.7K | Mar 30, 2026 |
| FY2025 | Dec 31, 2023 | $1.62M | Mar 30, 2026 |
| FY2024 | Dec 31, 2022 | $5.58M | Mar 28, 2025 |
| FY2023 | Dec 31, 2021 | $2.97M | Mar 26, 2024 |
| FY2022 | Dec 31, 2020 | $1.70M | Mar 30, 2023 |
| FY2020 | Dec 31, 2019 | ($2.92M) | Apr 12, 2021 |
| FY2020 | Dec 31, 2018 | ($640.5K) | Apr 12, 2021 |
| FY2019 | Dec 31, 2017 | ($861.8K) | Apr 3, 2020 |
| FY2018 | Dec 31, 2016 | ($347.9K) | Apr 1, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($134.86M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($119.99M) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($110.81M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($103.46M) | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | ($97.69M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($92.27M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($89.04M) | Apr 12, 2021 |
| FY2019 | Dec 31, 2018 | ($83.48M) | Apr 3, 2020 |
| FY2018 | Dec 31, 2017 | ($80.47M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($79.68M) | Apr 17, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.44M | Mar 30, 2026 |
| FY2024 | Dec 31, 2024 | $164.8K | Mar 28, 2025 |
| FY2024 | Dec 31, 2023 | $1.32M | Mar 28, 2025 |
| FY2022 | Dec 31, 2022 | $5.64M | Mar 30, 2023 |
| FY2022 | Dec 31, 2021 | $3.66M | Mar 30, 2023 |
| FY2020 | Dec 31, 2020 | $3.32M | Apr 12, 2021 |
| FY2020 | Dec 31, 2019 | $88.4K | Apr 12, 2021 |
| FY2020 | Dec 31, 2018 | $178.6K | Apr 12, 2021 |
| FY2019 | Dec 31, 2017 | $2.8K | Apr 3, 2020 |
| FY2018 | Dec 31, 2016 | $680 | Apr 1, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $1.13M | Apr 12, 2021 |
| FY2019 | Dec 31, 2019 | $1.50M | Apr 3, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 31, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 30, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 229.58M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 213.86M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | 211.24M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 210.85M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | 207.56M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 190.53M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 206.57M | Apr 12, 2021 |
| FY2019 | Dec 31, 2018 | 201.70M | Apr 3, 2020 |
| FY2018 | Dec 31, 2017 | 157.79M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 154.79M | Apr 17, 2018 |